Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-08

Clinical Trial Update: Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties, [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing Sialanar Plus/Al rehabilitation versus placebo/rehabilitation for severe sialorrhea in children/adolescents with neurodisabil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sialanar Plus

Snippet

Sponsor: Proveca Pharma Limited | Conditions: Sialorrhea, Neurodevelopmental Disorders | Phase 4 | Status: UNKNOWN